Coloplast looks to maintain growth

In a Wall Street Journal interview, Coloplast CEO Lars Rasmussen emphasized the focus on chronic care, including new acquisitions, despite some analysts worries that the company's fast growth could falter. "We must create stable long-term growth there, so that's where we invest most right now," Rasmussen said. Also, the company--which specializes in chronic ostomy and continence care--plans to cut outdated products to push profitability in its device profile. Interview

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.